In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene

BACKGROUND: Dihydroartemisinin-piperaquine is a new ACT that is administered as single daily dose for three days and has been demonstrated to be tolerated and highly effective for the treatment of uncomplicated Plasmodium falciparum malaria. Piperaquine was used alone to replace chloroquine as the f...

Full description

Saved in:
Bibliographic Details
Published in:Malar J
Main Authors: Pascual, Aurélie, Madamet, Marilyn, Bertaux, Lionel, Amalvict, Rémy, Benoit, Nicolas, Travers, Dominique, Cren, Julien, Taudon, Nicolas, Rogier, Christophe, Parzy, Daniel, Pradines, Bruno
Format: Artigo
Language:Inglês
Published: BioMed Central 2013
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4225597/
https://ncbi.nlm.nih.gov/pubmed/24274185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-12-431
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items